Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Virgen Macarena (27)

2023

  1. Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity

    Clinical and Translational Oncology, Vol. 25, Núm. 11, pp. 3073-3085

  2. Overlapping versus single long stents in long chronic total occlusions: insights of the Iberian CTO Registry

    Minerva cardiology and angiology, Vol. 71, Núm. 3, pp. 284-293

  3. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

2022

  1. Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487

  2. Erratum to “Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO” [Med Clin (Barc). 2020;155(12):521-528] (Medicina Clinica (2020) 155(12) (521–528), (S0025775320301895), (10.1016/j.medcli.2020.01.033))

    Medicina Clinica

  3. Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure

    Heart (British Cardiac Society), Vol. 108, Núm. 14, pp. 1098-1106

  4. Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 1, pp. 4-11

2021

  1. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

  2. Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 438-448

2020

  1. Effectiveness of sacubitril–valsartan in cancer patients with heart failure

    ESC Heart Failure, Vol. 7, Núm. 2, pp. 763-767

  2. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  3. Major bleeding predictors in patients with left atrial appendage closure: The iberian registry ii

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-11

  4. Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO

    Medicina Clinica, Vol. 155, Núm. 12, pp. 521-528

2019

  1. Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 749-759

  2. Left atrial appendage occlusion as adjunctive therapy to anticoagulation for stroke recurrence

    Journal of Invasive Cardiology, Vol. 31, Núm. 8, pp. 212-216

  3. Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry

    Revista Espanola de Cardiologia, Vol. 72, Núm. 5, pp. 373-382

  4. Replied to “Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018)”

    Clinical and Translational Oncology

  5. SEOM clinical guidelines on cardiovascular toxicity (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 94-105

  6. Spanish Catheter Ablation Registry. 18th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2018)

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1031-1042

2018

  1. Selection of the Best of 2017 in Implantable Defibrillators

    Revista Espanola de Cardiologia, Vol. 71, Núm. 4, pp. 304-305